UY28282A1 - Mediadores peptidicos del trasporte inverso de colesterol para el tratamiento de hipercolesterolemia - Google Patents

Mediadores peptidicos del trasporte inverso de colesterol para el tratamiento de hipercolesterolemia

Info

Publication number
UY28282A1
UY28282A1 UY28282A UY28282A UY28282A1 UY 28282 A1 UY28282 A1 UY 28282A1 UY 28282 A UY28282 A UY 28282A UY 28282 A UY28282 A UY 28282A UY 28282 A1 UY28282 A1 UY 28282A1
Authority
UY
Uruguay
Prior art keywords
hypercholesterolemia
treatment
pestidic
colesterol
mediators
Prior art date
Application number
UY28282A
Other languages
English (en)
Inventor
Jagadish C Sircar
Kashinatham Alisala
Igor Nikoulin
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Publication of UY28282A1 publication Critical patent/UY28282A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Composiciones derivadas de aminoácidos adaptados para mejorar el transporte inverso de colesterol en mamíferos. Las composiciones derivadas de aminoácidos son adecuadas para una administración oral y de utilidad en el tratamiento y/o la prevención de hipercolesterolemia, aterosclerosis y las enfermedades cardiovasculares asociadas.
UY28282A 2003-04-22 2004-04-22 Mediadores peptidicos del trasporte inverso de colesterol para el tratamiento de hipercolesterolemia UY28282A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46466703P 2003-04-22 2003-04-22

Publications (1)

Publication Number Publication Date
UY28282A1 true UY28282A1 (es) 2004-11-30

Family

ID=33310929

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28282A UY28282A1 (es) 2003-04-22 2004-04-22 Mediadores peptidicos del trasporte inverso de colesterol para el tratamiento de hipercolesterolemia

Country Status (18)

Country Link
US (1) US20060166891A1 (es)
EP (1) EP1615954A2 (es)
JP (1) JP2007534612A (es)
KR (1) KR20050114283A (es)
CN (1) CN1809590A (es)
AR (1) AR044058A1 (es)
AU (1) AU2004233333A1 (es)
BR (1) BRPI0409609A (es)
CA (1) CA2522758A1 (es)
CL (1) CL2004000858A1 (es)
IS (1) IS8072A (es)
MX (1) MXJL05000046A (es)
NO (1) NO20055474L (es)
PE (1) PE20050136A1 (es)
RU (1) RU2005135139A (es)
TW (1) TW200503747A (es)
UY (1) UY28282A1 (es)
WO (1) WO2004094471A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXJL06000070A (es) * 2004-06-09 2007-04-10 Avanir Pharmaceuticals Pequenas moleculas para el tratamiento de hipercolesterolemia y enfermedades relacionadas.
CA2568543A1 (en) * 2004-06-09 2005-12-29 Avanir Pharmaceuticals Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
PE20050986A1 (es) * 2004-06-09 2006-02-03 Avanir Pharmaceuticals Derivados heterociclicos mediadores del transporte inverso de colesterol
WO2006049597A1 (en) * 2004-10-27 2006-05-11 Avanir Pharmaceuticals Amino acid-derived compounds as modulators of the reverse cholesterol transport
WO2007055873A2 (en) * 2005-11-04 2007-05-18 Avanir Pharmaceuticals Process for the manufacture of peptide facilitators of reverse cholesterol transport
EP2037928B1 (en) 2006-06-26 2012-01-11 Amgen Inc. Methods for treating atherosclerosis
WO2009086096A2 (en) * 2007-12-21 2009-07-09 University Of Cincinnati Therapeutic use of carboxyl ester lipase inhibitors
GB0918579D0 (en) * 2009-10-22 2009-12-09 Imp Innovations Ltd Gadd45beta targeting agents
US20110152112A1 (en) * 2009-12-23 2011-06-23 Artery Therapeutics, Inc. Diagnosis and treatment of reverse cholesterol transport deficiency-related diseases
US20110288017A1 (en) * 2010-03-01 2011-11-24 Leslie Frost Apo-lipoprotein propeptide
WO2017208149A1 (en) 2016-05-31 2017-12-07 Institut De Cardiologie De Montreal A co-culture system and method for in vitro assessment of reverse cholesterol transport
CA3125767A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE437153B (sv) * 1976-12-01 1985-02-11 Kabi Ab Specifika kromogena enzymsubstrat for serinproteaser
US4448715A (en) * 1981-11-02 1984-05-15 University Of Miami Tagged pyroglu-L-Phe-L-Arg derivatives, substrates and assays for kallikrein
US4643988A (en) * 1984-05-15 1987-02-17 Research Corporation Amphipathic peptides
DE3781263T2 (de) * 1986-12-15 1993-04-08 Inst Nat Sante Rech Med Peptid-derivate und deren verwendung in der therapie.
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
WO1999003880A1 (en) * 1997-07-15 1999-01-28 Novo Nordisk A/S Nociceptin analogues
US6037323A (en) * 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6821774B1 (en) * 1999-06-18 2004-11-23 Cv Therapeutics, Inc. Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
EP2343317A1 (en) * 2000-11-10 2011-07-13 F. Hoffmann-La Roche Ltd. Apolipoprotein analogues
US20040003418A1 (en) * 2001-04-10 2004-01-01 Aya Jakobovits Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer

Also Published As

Publication number Publication date
TW200503747A (en) 2005-02-01
KR20050114283A (ko) 2005-12-05
US20060166891A1 (en) 2006-07-27
MXJL05000046A (es) 2005-12-22
AR044058A1 (es) 2005-08-24
IS8072A (is) 2005-10-13
CL2004000858A1 (es) 2005-04-22
BRPI0409609A (pt) 2006-04-18
JP2007534612A (ja) 2007-11-29
WO2004094471A3 (en) 2005-06-16
CN1809590A (zh) 2006-07-26
EP1615954A2 (en) 2006-01-18
NO20055474D0 (no) 2005-11-18
NO20055474L (no) 2006-01-23
AU2004233333A1 (en) 2004-11-04
PE20050136A1 (es) 2005-04-20
RU2005135139A (ru) 2007-05-27
WO2004094471A2 (en) 2004-11-04
CA2522758A1 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
UY28953A1 (es) Derivados heterocíclicos para el tratamiento de hiperlipidemia y enfermedades relacionadas
PT1411908E (pt) Tratamento de infeccoes da unha com no
UY28282A1 (es) Mediadores peptidicos del trasporte inverso de colesterol para el tratamiento de hipercolesterolemia
EP3533461A3 (en) Prame derived peptides and immunogenic compositions comprising these
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
MY138708A (en) Biaryloxymethylarenecarboxylic acids
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
BRPI0415639A (pt) formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia
DE60307860D1 (de) Aminocyclohexenchinoline und ihre azaisosterischen analoga mit antibakterieller wirkung
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
HRP20050924A2 (en) Cladribine formulations for improved oral and transmucosal delivery
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
CY1115938T1 (el) Νεα συνθεση για αυξηση της bio-διαθεσιμοτητας της νεουρτουρινης (neurturin)
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
RS54185B1 (en) USE OF 24-ORDER
DE502005008925D1 (de) Substituierte nonadepsipeptide
ATE358992T1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
WO2010057275A8 (en) Cyclic peptides and uses thereof
UY28951A1 (es) Pequenas moleculas para el tratamiento de hipercolesterolemia y enfermedades relacionadas
UY28952A1 (es) Mediadores del transporte inverso de colesterol para el tratamiento de la hipercolesterolemia
NO20023640D0 (no) Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner
DE502006004735D1 (de) Mittel zur behandlung von infektionen
RU2010126053A (ru) Применение аналогов соматостатина при менингиоме

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150522